Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07174089 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

New AI-based Technologies in Nuclear Medicine

Study acronym: AI-basedMedNuc
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study completion date: Mar 31, 2026 to Dec 31, 2026v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study aims to identify and predict radiopharmaceutical extravasation events using new semi-quantitative parameters and machine learning models. It involves dose rate measurements to develop metrics for real-time monitoring. It also investigates the correlation between extravasation and SUV correction in PET/CT diagnostics, providing an estimate of the correction factor necessary for accurate SUV evaluation in case of an extravasation event.
Trial Details
NCT Number NCT07174089
Lead Sponsor Azienda USL Reggio Emilia - IRCCS
Conditions
(from sponsor)		 Patients Undergoing PET/CT Investigation or Nuclear Medicine Therapy
Enrollment 1,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov